:

PERCEPTIC RAISES $12M FOR AI DRUG DEVELOPMENT

AI DESK1 MIN READ
TUE, MAY 26, 2026

■ AI-SUMMARIZED FROM 1 SOURCE ▸ TIMELINE

London-based Perceptic closed a $12 million seed round led by Accel to expand its end-to-end AI platform for pharmaceutical development. The startup was founded by three former Palantir executives who built Palantir's Life Sciences practice.

Perceptic positions itself as a comprehensive AI solution for drug development, with backing from top pharmaceutical companies already using the platform. The funding comes as the biotech sector increasingly adopts machine learning to accelerate research and reduce development timelines. The startup's founding team brings significant enterprise software experience from Palantir, where they developed tools for intelligence and data analysis. This expertise translates directly to pharma's complex data challenges around molecular analysis, clinical trials, and drug candidate identification. Ackel's investment signals confidence in AI-driven drug development as a category. The $12 million seed round will likely fund platform expansion and talent recruitment. Perceptic joins a growing cohort of AI-first biotech platforms targeting the $2 trillion pharmaceutical industry. The company operates in a competitive space alongside initiatives from established pharma giants and well-funded startups, though its enterprise pedigree differentiates its approach to regulatory-grade AI systems.

■ SOURCES

Techmeme

■ SUMMARY WRITTEN BY AI FROM THE LINKS ABOVE

■ MORE FROM THE STARTUPS DESK

SolarSquare is in talks to raise up to $60 million in funding, with a potential valuation of $500 million. The financing round reflects growing venture capital interest in India's rooftop solar market.

YESTERDAYAI Desk

College social app Fizz has expanded its lawsuit against competitor Sidechat, alleging that a Maveron venture capitalist shared confidential information obtained during a 2022 fundraising pitch with the rival startup.

YESTERDAYIndustry Desk

Phia, a shopping app co-founded by Phoebe Gates, is allegedly using cookie stuffing—a fraudulent technique involving fake clicks—to claim unearned affiliate commissions. The startup has raised $43.5 million to date.

JUL 10AI Desk

Toni Schneider has been promoted from interim to permanent CEO of Bluesky, four months after taking the role in March. Schneider, formerly CEO of Automattic, commits to leading the decentralized social platform.

JUL 10Industry Desk

■ SUBSCRIBE TO THE DAILY BRIEF

ONE EMAIL, 5 STORIES, 06:00 UTC. UNSUBSCRIBE ANYTIME.